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https://doi.org/10.1016/j.stemcr.2018.01.025SUMMARYUse of hepatocytes derived from induced pluripotent stem cells (i-Heps) is limited by their functional differences in comparison with
primary cells. Extracellular niche factors likely play a critical role in bridging this gap. Using image-based characterization (high
content analysis; HCA) of freshly isolated hepatocytes from 17 human donors, we devised and validated an algorithm (Hepatocyte
Likeness Index; HLI) for comparing the hepatic properties of cells against a physiological gold standard. The HLI was then applied
in a targeted screen of extracellular niche factors to identify substrates driving i-Heps closer to the standard. Laminin 411, the top
hit, was validated in two additional induced pluripotent stem cell (iPSC) lines, primary tissue, and an in vitro model of a1-antitrypsin
deficiency. Cumulatively, these data provide a reference method to control and screen for i-Hep differentiation, identify Laminin 411 as
a key niche protein, and underscore the importance of combining substrates, soluble factors, and HCA when developing iPSC appli-
cations.INTRODUCTION
Stem cell-derived hepatocytes offer an exciting and novel
resource for use in human disease modeling and cell
therapy. Both embryonic (induced pluripotent stem cell
[PSC]/embryonic stem cell [ESC]) and adult stem cell-der-
ived products remain unsuitable for target downstream
applications due to comparatively poor functionality
when tested against primary adult counterparts (reviewed
in Rashid et al., 2015). Extracellular signals delivered via a
complex 3-dimensional protein-rich environment termed
the ‘‘niche’’ tightly regulate hepatocyte function (Orford
and Scadden, 2008; Morrison and Spradling, 2008).
Recent attempts at enhancing the function of hepatocytes
derived from iPSCs (i-Heps) by targeting the niche (Shan
et al., 2013; Wang et al., 2017), though promising, are still
unable to bridge the gap in functionality. One of the
major reasons for this failure is the lack of a systematic
approach to empirically define a signature of maturity
that must be crossed in order for i-Heps to become suitably
useful.
The aim of this study was therefore to (1) define a profile
of healthy, freshly isolated primary hepatocytes (Hepato-
cyte Likeness Index; HLI) that cells of interest can be
compared against for high-throughput screening (HTS),Stem Cell Rep
This is an open access arti(2) apply this platform to screen hepatocyte niche factors
for their ability to drive i-Heps closer to that target, and
(3) validate our findings in a pharma-like screening
environment.RESULTS
High Albumin Expression in Combination with Select
Morphological Characteristics Defines a Functionally
Relevant Hepatocyte Signature and Enables
Calculation of the Hepatocyte Likeness Index
To define the profile of a target healthy hepatocyte, we first
measured hepatocyte morphology and protein expression
in hepatocytes freshly isolated fromnormal fetal, neonatal,
and adult livers (n = 17, Table S1) and used this information
to construct the HLI for comparing other cell types of inter-
est (Figure 1).
Measurement of morphological properties revealed
statistically significant differences in all parameters be-
tween fetal, pediatric, and adult hepatocytes (Figure S1).
True multivariate analysis (Random Forest) identified
cell width, cell area, and cell symmetry as the three
most important characteristics that differentiated human
hepatocytes from non-hepatocyte cell types. Comparedorts j Vol. 10 j 693–702 j March 13, 2018 j Crown Copyright ª 2018 693
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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with adult hepatocytes, fetal hepatocytes were smaller
and less symmetrical. Nuclear area and width also distin-
guished the physiological age of primary hepatocytes
with nuclear polyploidy, as expected, being observed in
approximately 30% of hepatocytes from adult liver sam-
ples but in less than 5% of cells from fetal liver. i-Heps, on
the other hand, resembled primary adult hepatocytes in
symmetry but had larger nuclei. Significant variation in
their nuclear and cell sizes was also observed, with larger
i-Hep morphology correlating poorly with albumin
expression. Though promising, the discriminatory ability
offered by the above morphological analyses was there-
fore not enough to proceed to HTS. To improve the accu-
racy of our index, we therefore evaluated the added value
of simultaneously measuring protein expression. Quanti-
fication of protein expression by fluorescence intensity
was previously widely reported for a broad spectrum
of biological applications similar to ours (Young et al.,
2008; Massey, 2015; Boehnke et al., 2016; Rodriguez-
Muela et al., 2017), making the approach suitable for
this study. We therefore tested in different concentra-
tions, exposure times, and excitation levels a panel of
immunofluorescent antibodies whose target proteins
had previously been reported to correlate with hepato-
cyte function (Rowe et al., 2013; Baxter et al., 2015)
(Figure S2). Analysis of protein expression by mean fluo-
rescence intensity (MFI) in this manner showed discrim-
inatory signatures between i-Heps, fetal hepatocytes, and
adult hepatocytes. Albumin expression was found to be
the most accurate biomarker for hepatocyte identifica-
tion in this regard (Figure 1B), correlating best with
cellular metabolic function (Figure 1C). The validity of
albumin MFI as a surrogate marker for cellular albumin
protein level was then confirmed using orthogonal assaysFigure 1. Generation of the Hepatocyte Likeness Index
(A) Schematic representation of work-flow that established morpholog
Index (HLI) and its validation across different cell types. AH, adult h
(B) Image-based algorithm enables the automated identification of
albumin staining in adult hepatocytes (AH), i-Heps (IH), and fibrobla
hepatocytes; gray or red highlighted cells are recognized as non-hep
(C) (Top) Receiver-operating characteristic curve demonstrating high
likeness and maturity. (Bottom) Pearson correlation analysis of show
(cytochrome 2A6) function (Pearson coefficient r2 = 0.9503, 95% co
(D) Mean fluorescence intensity (MFI) of albumin is validated by ELISA
(IH), and fibroblasts (F). n = 9 donors (AH), n = 4 donors (FH), n = 3
(E) HLI discriminates freshly isolated adult hepatocytes from cryopre
i-Heps in a manner independent of cell viability (n = 3 different biol
(F) HLI discriminates hepatocytes from other cells in vivo. (Left panel)
albumin-positive and albumin-negative (blue) cells. (Right panel)
hepatocytes (green) from non-hepatocytes (red) by machine learn
non-hepatocyte cells around periportal area. Scale bar, 100 mm.
(G) HLI discriminates hepatocytes from other cells in vitro. Co-culture
were discriminated by HLI (right panel) better than by flow cytometrsuch as qPCR and ELISA (Figure 1D). Reassuringly, these
experiments demonstrated that increased albumin MFI
levels corresponded with relative increases in hepatic
function across multiple independent experiments and
biological samples.
Incorporating the above data (morphology + albumin
MFI), an analysis sequence that enabled supervised
machine learning was constructed for the automated iden-
tification of bona fide hepatocytes—firstly by nuclear
morphology, then cell morphology, and finally albumin
expression (Figure S3). Cells satisfying normal parameters
(of freshly isolated hepatocytes) were classified as ‘‘hepato-
cyte positive’’ and others ‘‘hepatocyte negative.’’ The HLI
was then defined as the proportion of positively identified
hepatocytes over the total number of cells analyzed.
Therefore, in a population of healthy primary adult hepa-
tocytes HLI approximates 1 and in a negative biological
control (e.g. fibroblasts), HLI approximates 0. We next
validated the physiological relevance of this index by
measuring HLI in different cell populations (Figure 1E)
to show how the algorithm could be used to not only
differentiate hepatocytes from non-hepatic cells but also
to discriminate freshly isolated adult hepatocytes from
cryopreserved adult, cultured adult, and freshly isolated
fetal hepatocytes in a manner independent of cell viability
(Figure 1E). The HLI was also capable of identifying bona
fide hepatocytes within heterogeneous cell populations
such as is found in human liver tissue (Figure 1F) or in
in vitro co-culture systems (Figure 1G) with a higher accu-
racy than flow cytometry. Finally, we demonstrated that
the HLI could readily be transferred to other image anal-
ysis platforms (Figure S3) before proceeding to screen for
the effects of hepatocyte niche factors on i-Hep HLI
(Figure 2).ical parameters and protein signatures for the Hepatocyte Likeness
epatocytes (n = 17 donors); F, fibroblasts (n = 3 donors).
hepatocytes by morphology and albumin. (Left column) DAPI and
sts (F). (Right column) Cells highlighted green represent identified
atocytes. Scale bar, 200 mm.
diagnostic ability of albumin as a surrogate marker of hepatocyte
ing that high albumin expression is closely related with metabolic
nfidence interval, p < 0.01).
and qPCR in adult hepatocytes (AH), fetal hepatocytes (FH), i-Heps
donors (IH), and n = 3 donors (F). Error bars show mean ± SD.
served adult, cultured adult, freshly isolated fetal hepatocytes, and
ogical samples in all groups, all independent experiments).
Human liver section (103) stained for albumin (red) demonstrating
Application of HLI algorithm enables automated detection of
ing. Enlarged square: accurate distribution of hepatocytes and
of GFP-labeled HUVECs (green) and hepatocytes (red) (left panel)
y (right). Scale bar, 100 mm.
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Figure 2. Screening of Niche Factors Using HLI Algorithm Demonstrates Effect of Laminin 411 in i-Heps
(A) The HLI algorithm (y axis) was used to screen for the effects of 58 different hepatocyte niche factors (x axis) on i-Heps 7 days after
plating. Control line (red) is the control threshold based on culture with collagen-1.
(B) Revalidation of the eight hits from the first round of screening.
(legend continued on next page)
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A Screen of ECM Proteins and Soluble Niche Factors
Demonstrates that Laminin 411 Advances i-Heps
toward Functional Significance
Using the Human Matrisome Project database (http://
matrisomeproject.mit.edu) we identified 105 proteins
likely to be important in hepatocyte maturation. Of these,
a total of 58 proteins and niche factors were put forward
into the screen based on biological interest and commercial
availability (Table S2). From the initial screen, eight pro-
teins (Figure 2A) were found to have a positive effect
(HLI > 0.2) and taken forward for validation. Seven of the
eight proteins were found to be efficacious in the second
round (Figure 2B). The hit with the greatest effect on HLI,
Laminin 411, was then tested on i-Heps from three
different biological samples. In these conditions, cells dis-
played higher expression levels of genes known to be asso-
ciated with adult hepatocyte function such as CYP2C9,
ASGPR1, HNF4A, CEBP/A, and ALB (Figure 2C). Finally,
immunofluorescence staining for albumin confirmed that
i-Heps cultured in Laminin 411 for 2 weeks have higher
protein expression with more cells meeting morphological
parameters of a normal hepatocyte (Figure 2D).
Laminin 411 Is a Component of the Hepatic Niche in
Human Fetal Liver
Next, we investigated the importance of Laminin 411
during human liver development. We obtained freshly iso-
lated human fetal hepatocytes from 16- to 20-pcw (post-
coital weeks) donor tissue (n = 3 donors) and observed
similar effects of culturing these cells on Laminin 411 as
with i-Heps. Compared with collagen-1, Laminin 411
improved cell survival and morphology (Figure 3A) while
retaining a higher population of cells mirroring the adult
hepatocyte phenotype (Figure 3B). Gene expression anal-
ysis confirmed a statistically significant increase in the
expression of ALB, HNF4A, CYPA1, and CYP2C9 (Fig-
ure 3C). We then hypothesized that if Laminin 411 is
relevant to human physiology of hepatocytes, it would
also be expressed in liver. For this purpose, we analyzed
gene expression databases for genes expressing ECM pro-
teins in adult versus fetal versus iPSC-endoderm tissue.
This analysis demonstrated upregulation of LAMA4 and
LAMB1 (the constituent components of LAM-411) in
human fetal liver (Figure 3D). We confirmed this computa-
tional presumption using RNA in situ hybridization, and
found high expression of LAMA4 near vascularized regions(C) Relative gene expression of i-Heps cultured on Laminin 411 (middle
freshly isolated adult hepatocytes (AH) as control (right bars). n = 3 (
show mean ± SD; *p < 0.05, ***p < 0.01.
(D) Immunofluorescence staining for albumin (red, left), DAPI (blue, l
411 (top) versus collagen-1 (bottom); cell morphology is shown on
represent n = 3 different biological replicates and independent experof maturing human fetal liver and only very weak expres-
sion in adult liver (Figure 3E).Laminin 411 Prolonged Survival of Hepatic Progenitor
Cells and Is Better Suited for i-Hep-Based Drug-
Screening Applications
Lastly we sought to examine whether our findings had
identified a substrate more suitable for use with an iPSC
a1-antitrypsin deficiency (A1AT-Z) disease model drug-
screening platform (Yusa et al., 2011). Cells were seeded
into 384-well plates coated with collagen-1 or Laminin
411 and evaluated for survival, disease signature, inter-
well variability, and response to the histone deacetylase
(HDAC) inhibitor suberoylanilide hydroxamic acid
(SAHA) (Bouchecareilh et al., 2012). After 28 days in culture
(Figure 4A), Laminin 411 demonstrated improved cell
survival and had a stronger disease signature of A1AT (Fig-
ure 4B) compared with collagen-1 when stained for
albumin and A1AT protein. Improvement in cell survival
was also observed in primary fetal hepatocytes; however,
similarly to current literature this effect was not seen in
primary adult hepatocytes (Watanabe et al., 2016).DISCUSSION
Here, we report the development of an imaging-based algo-
rithm capable of stratifying human hepatocyte maturity
in a high-throughput manner. With this capability, candi-
date extracellular niche factors were screened for their
capacity to drive i-Heps closer to hepatocytes freshly iso-
lated from human liver. The efficacy of themost significant
hit, Laminin 411, was confirmed in three different iPSC
lines and three different human fetal hepatocyte samples.
Translational relevance was then demonstrated by superior
performance of the substrate in a high-throughput drug-
screening platform for a1-antitrypsin deficiency.
Imaging-based assays represent an excellent modality for
studying the effects of extracellular niche components in a
high-throughput manner. Bhatia and colleagues recently
reported the development of an exciting high-throughput,
imaging-based genetic screening platform to identify the
most critical stromal cell gene products involved in stabili-
zation of primary humanhepatocyte functions (Shan et al.,
2016). Our work extends the significance of such studies by
using freshly isolated hepatocytes, the physiological goldbars) compared with collagen-1 (left bars) with expression levels in
different i-Hep cell lines and independent experiments); error bars
eft middle) and merge (middle right), of i-Heps cultured on Laminin
far right (103 magnification; scale bar, 100 mm). Images shown
iments. Scale bar, 200 mm.
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standard in the field (instead of frozen cells) to construct a
‘‘hepatocyte-ness’’ score (the HLI) for measuring the effects
of substrates on stem cell-derived hepatocytes. These tools
are, we believe, essential for expediting effective transla-
tional outputs in this field, with the generalizability of
the platform (reproducibility across multiple image anal-
ysis platforms, cell lines, and commercially available sub-
strates) suggesting that rapid adaptation by others could
easily be achieved.
Results fromthe screenperformedhighlighted the impor-
tant role played by laminins, a group of heterotrimeric
ECM proteins, in the hepatic progenitor response. This
association had previously been reported in adult liver (Kal-
lis et al., 2011) and in cholangiocyte differentiation
(Takayama et al., 2016) but not in embryonic hepatocyte
development. Here we demonstrated Laminin 411 to be a
biologically relevant and important factor in advancing
i-Hep differentiation and in human hepatic fetal develop-
ment (Figure 3). Although its specific role remains unclear,
its structure comprising a-4 (LAMA4), b-1, and g-1 chains,
facilitates binding to a6b1 and a6b4 integrin receptors, sug-
gesting that its effects may be due to activation of several
receptors orpathwaysyet tobe fully elucidated. Thishetero-
geneity opens up the likelihood of downstream function
being a consequence of co-engagementwith a combination
of as yet poorly defined soluble and insoluble factors. Our
future efforts will therefore seek to unravel these complex
interactions by combining soluble factors with insoluble
ECM proteins in more sophisticated HTS screens. In the
meantime, as shown by our A1AT drug-screening data (Fig-
ure 4), information from even the most basic of screens
using the algorithmcan rapidly be translated intomeaning-
ful advances, which in turn suggests that our approach
could be of widespread utility in the field.EXPERIMENTAL PROCEDURES
Cells
All human tissues were collected with informed consent
following ethical and institutional guidelines. Freshly isolatedFigure 3. Laminin 411 Is a Physiologically Relevant Niche Factor
(A) Morphology (203) of fetal hepatocytes cultured on collagen-1 (to
plating (scale bar, 200 mm). Immunofluorescence staining (right) fo
100 mm).
(B) Number of albumin-expressing fetal hepatocytes identified by HLI
at day 5. n = 3 different biological samples and independent experim
(C) Relative gene expression (y axis) of fetal hepatocytes cultured fo
compared with adult liver (right bars). n = 3 (different biological sam
*p < 0.05.
(D) ECM gene expression heatmap comparing iPSC-derived endoderm
(E) RNA in situ hybridization for LAMA4 on a 16-pcw liver slide (left) (40
in the square compared with adult liver (right).hepatocytes were obtained from Triangle Research Labs, the
Institute of Liver Studies (King’s College Hospital), while fetal
livers were obtained from the Human Developmental Biology
Resource of University College London. Isolated adult hepato-
cytes were plated on 96-well collagen-1-coated plates (Greiner)
at a density of 10,000 cells per well and maintained in commer-
cially supplied media. Fetal hepatocytes were obtained from
16- to 20-week-old fetuses, dissociated as previously described
(Gramignoli et al., 2012) and cultured in collagen-1 or Laminin
411 (Biolamina, 10 mg/mL) while being maintained on DMEM
supplemented with insulin (Sigma) and dexamethasone (Sigma)
(107 M).
Human i-Heps were obtained from Definigen as a cryopreserved
sample and recovered for 10 days as per manufacturer’s instruc-
tions (ref. 16; A, patient 2 line 1; B, patient 1 line 1; C, patient 3
line 1) or supplied from the Nakauchi lab (TkDA line as used in
Takebe et al., 2013). Cells were plated on flat-bottomed 96-well
plates pre-coated with collagen-1 or Laminin 411 (as previously
described) at a density of 1.25 3 105 cells per well. Cultures were
maintained in Hepatozyme medium (Life Technologies), supple-
mented with 1% L-glutamine, 1% penicillin/streptomycin, 2%
non-essential amino acids (Life Technologies), 2% lipid concen-
trate (Life Technologies), 0.1% insulin-transferrin-selenium
(Sigma), 0.01 mg/mL oncostatin M (Peprotech), and 0.05 mg/mL
hepatocyte growth factor (Peprotech).
For the co-culture system, hepatocytes were cultured in a 1:1
ratio with nuclear GFP-labeled human umbilical vein endothelial
cells (HUVECs) (Essen Bioscience) using a 1:1 mix of Hepatozyme
and EGM (Lonza).
Human fibroblasts from three donors were isolated from skin
explants dissociation and cultured in collagen-coated 96-well
plates at a density of 500,000 cells/mL.
Cell viability was determined by trypan blue (Invitrogen) exclu-
sion and all cells were fixed 4% (w/v) paraformaldehyde phosphate
buffer solution (PFA; Sigma) after 48 hr of plating.ECM Screening
Proteins were used individually, in pairs, or in combinations of
three at five different concentrations by overnight coating of
96-well plates. Concentrations used for coating were dependent
on the target protein. I-Heps were plated for 7, 14, and 28 days
before being fixed, stained, and imaged as per the protocol defined
earlier. The most significant hits from the first round were takenin Fetal Liver Development
p) versus Laminin 411 (bottom) at 2 (left) and 5 (middle) days post
r albumin (red) plus DAPI (blue) at 5 days post plating (scale bar,
algorithm (y axis), cultured on Laminin 411 versus collagen (x axis)
ents; data presented as mean ± SD; *p < 0.05.
r 7 days on Laminin 411 (middle bars) versus collagen 1 (left bars)
ples and independent experiments); data presented as mean ± SD;
(left) with adult (middle) and fetal (right) liver.
3magnification; scale bar, 50 mm). Detail of the red dots expanded
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Figure 4. Laminin 411 Is Better Suited for Drug Screening in an i-Hep Disease Model of a1-Antitrypsin Deficiency
(A) I-Heps plated on 384-well plates coated with Laminin 411 or collagen-1 (left) were cultured for 14 days then imaged using the HLI
(scale bar, 1 mm) i-Heps cultured on Laminin 411 responded to SAHA treatment (top right) and have more function than albumin-pro-
ducing cells (bottom right). Data presented as mean ± SD; n = 3 biological replicates from independent experiments; *p < 0.05.
(B) Enlarged images from (A) showing immunofluorescence staining of i-Heps, DAPI (blue top left), albumin (red top right), A1AT (green
bottom left), and MERGE (yellow bottom right; scale bar, 50 mm). MFI for images were quantified (right graph) and showed higher MFI of
both A1AT and albumin in Laminin 411 (middle bars) compared with collagen-1 (outer bars). Data presented as mean ± SD; n = 3 biological
replicates from independent experiments; *p < 0.05.forward into a secondary screen using two additional iPSC cell
lines generated using two separate protocols (Rashid et al., 2010;
Mallanna and Duncan, 2013).700 Stem Cell Reports j Vol. 10 j 693–702 j March 13, 2018Image Analysis
Staining with CellMask blue was used for cell segmentation,
images captured with Operetta (PerkinElmer), and analysis
performed by PhenoLOGIC software (PerkinElmer) to identify
parameters that co-relate most closely with physiological hepato-
cyte likeness. Albumin staining in primary hepatocytes was found
to be equal to CellMask blue for cell segmentation. Areas under
receiver-operating characteristic curves were plotted using XLSTAT
and Prism (GraphPad) to determine the optimum cutoff fluores-
cent intensities.
For the 384-well plates, images were taken with a 103 objective
on the GE IN Cell Analyzer 6000.
Immunofluorescent Staining
After fixation, cells were blocked and permeabilized in 1% (w/v)
BSA (Sigma-Aldrich), 3% donkey serum (Life Technologies), and
0.1% Triton X-100. Primary antibodies (Table S3) were applied
for 1 hr. After washes, cells were incubated with Alexa 647,
Alexa 568, Jackson 488-conjugated secondary antibodies (Life
Technologies). Slides were counterstained with DAPI (NucBlue)
(Life Technologies).
Paraffin-embedded sections (5 mm thickness) were dewaxed,
rehydrated, and subjected to an antigen retrieval procedure with
sodium citrate (Sigma) (pH 6.0) before following the staining
procedure as described above.
Real-Time PCR Analysis
Total RNA was harvested using TRI reagent (Sigma), treated with
DNase (Promega), and phenol/chloroform purified. For each sam-
ple 0.5 mg of total RNA was reverse transcribed using a SuperScript
VILO cDNA Synthesis kit (Thermo Fisher Scientific). A typical
RT-PCR reaction contained 10 ng of sample cDNA, 0.0075 mL of
individual forward and reverse primer each at 100 mM stock,
5 mL of Taqman Universal Master mix (Applied Biosystems),
1 mL of Taqman target probe (Table S4), and made up to 10 mL
with nuclease-free water. Real-time PCR reactions were amplified
for 40 cycles on a CFX384 Touch Real-Time PCR Detection System
(Bio-Rad) in triplicate and normalized to ACTB (Figure S4) in the
same run. Real-time RT-PCR data are presented as the mean
of three independent biological experiments, and error bars
indicate SEM.
Heatmap Generation
Heatmaps were generated from bulk RNA-sequencing data
collected from three human fetal livers (two 14-pcw samples and
one 16 pcw), three human adult livers (female 18 years, male
13 years, and female 36 years), and three i-Hep samples harvested
at day 6 (endodermal stage) from the BOB cell line. Starting with
1 mg input total RNA, rRNA was removed using a Ribo-Zero Gold
rRNA Removal kit (Illumina). Sequencing libraries were prepared
using NEBNext Ultra Directional RNA Library Prep Kit for Illumina
(NEB) using 100 ng of rRNA-depleted sample and sequenced on a
HiSeq 2500 system in rapid run mode (Illumina) following a stan-
dard protocol. All libraries generated between 15 and 25 million
reads. Reads were mapped to GRCh38 reference genome using
Bowtie2 (Langmead and Salzberg, 2012). Raw counts and normal-
ized gene expression were generated using HT-Seq (Anders et al.,
2015) and DESEq2 (Love et al., 2014) packages, respectively. The
heatmap was generated using R (http://www.R-project.org/)
(R Development Core Team, 2008). Heatmaps represent averageDESEq2 normalized gene expression values of three independent
biological samples.
Human Albumin ELISA
Albumin production of all different cell types was assessed using
the Human Albumin Quantification Set (Bethyl Laboratories)
following the manufacturer’s instructions. Results shown are the
mean and SD of triplicate biological replicates. Absorbance was
measured using a GloMax-Multi Detection System (Promega) at
450 nm.
In Situ Hybridization
In situ hybridization for LAMA4 (Hs-LAMA4, cat. No. 459161)
expression was performed on 5-mm sections of 15- to 17-pcw fetal
and adult livers using the RNAscope 2.5 High Definition (Red, cat.
no. 322350, Advanced Cell Diagnostics, Hayward, CA) according
to the manufacturer’s instructions. Slides were counterstained
with Gill’s hematoxylin and analyzed under the Hamamatsu
scanner.
Data Analysis
Data were analyzed with GraphPad Prism for Pearson Correlation
Analyses and t tests. t Tests were plotted as mean ± SD or mean ±
SEM where specified. Phenologic and Spotfire (PerkinElmer) were
also used for multivariate analysis (Random Forrest), PCA plot,
and SOM algorithm.
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